108 related articles for article (PubMed ID: 1561232)
1. Does gentamicin induce acute renal failure by increasing renal TXA2 synthesis in rats?
Papanikolaou N; Peros G; Morphake P; Gkikas G; Maraghianne D; Tsipas G; Kostopoulos K; Arambatze C; Gkika EL; Bariety J
Prostaglandins Leukot Essent Fatty Acids; 1992 Feb; 45(2):131-6. PubMed ID: 1561232
[TBL] [Abstract][Full Text] [Related]
2. The role of prostaglandin and thromboxane synthesis by the glomeruli in the development of acute renal failure.
Chatziantoniou C; Papanikolaou N
Eicosanoids; 1989; 2(3):157-61. PubMed ID: 2629895
[TBL] [Abstract][Full Text] [Related]
3. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.
Hatziantoniou C; Papanikolaou N
Experientia; 1986 Jun; 42(6):613-5. PubMed ID: 3522267
[TBL] [Abstract][Full Text] [Related]
4. Delay of the initiation of hypertension in spontaneously hypertensive rats by CV-4151, a specific thromboxane A2 synthetase inhibitor.
Shibouta Y; Terashita Z; Inada Y; Nishikawa K
Eur J Pharmacol; 1985 Feb; 109(2):135-44. PubMed ID: 3922775
[TBL] [Abstract][Full Text] [Related]
5. Effects of thromboxane synthetase inhibitor (OKY-046) on urinary prostaglandin excretion and renal function in streptozotocin-induced diabetic rat.
Tajiri Y; Umeda F; Inoguchi T; Nawata H
J Diabetes Complications; 1994; 8(2):126-32. PubMed ID: 8061349
[TBL] [Abstract][Full Text] [Related]
6. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
[TBL] [Abstract][Full Text] [Related]
7. Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A.
Perico N; Benigni A; Zoja C; Delaini F; Remuzzi G
Am J Physiol; 1986 Oct; 251(4 Pt 2):F581-7. PubMed ID: 3094383
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of renal thromboxane biosynthesis increased sodium excretion rate in normal and saline-loaded rats.
Papanicolaou N; Gkika EL; Gkikas G; Bariety J
Clin Sci (Lond); 1985 Jan; 68(1):79-82. PubMed ID: 3880524
[TBL] [Abstract][Full Text] [Related]
9. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
[TBL] [Abstract][Full Text] [Related]
10. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
[TBL] [Abstract][Full Text] [Related]
11. Reduction of urinary albumin excretion by thromboxane synthetase inhibitor, OKY-046, through modulating renal prostaglandins in patients with diabetic nephropathy.
Tajiri Y; Inoguchi T; Umeda F; Nawata H
Diabetes Res Clin Pract; 1990; 10(3):231-9. PubMed ID: 2073870
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of thromboxane synthesis partially protected while inhibition of angiotensin II formation did not protect rats against acute renal failure induced with glycerol.
Papanicolaou N; Hatziantoniou C; Bariety J
Prostaglandins Leukot Med; 1986 Jan; 21(1):29-35. PubMed ID: 3513208
[TBL] [Abstract][Full Text] [Related]
13. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
Yoshida T; Ichikawa Y; Tojo T; Homma M
Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126
[TBL] [Abstract][Full Text] [Related]
14. Increased production of eicosanoids, TXA2, PGI2 and LTC4 in experimental spinal cord injuries.
Mitsuhashi T; Ikata T; Morimoto K; Tonai T; Katoh S
Paraplegia; 1994 Aug; 32(8):524-30. PubMed ID: 7970857
[TBL] [Abstract][Full Text] [Related]
15. Comparison of umbilical vein models for measurement of relative prostacyclin and thromboxane production.
Mehta P; Mehta J; Crews F; Roy L; Ostrowski N; Horalek C
Prostaglandins; 1982 Dec; 24(6):743-9. PubMed ID: 6820165
[TBL] [Abstract][Full Text] [Related]
16. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
Morimoto K; Ikata T; Tounai T
Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of thromboxane A2 activity during warm ischemia of the liver.
Shirabe K; Kin S; Shinagawa Y; Chen S; Payne WD; Sugimachi K
J Surg Res; 1996 Feb; 61(1):103-7. PubMed ID: 8769950
[TBL] [Abstract][Full Text] [Related]
18. Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites.
Gentilini P; Laffi G; Meacci E; La Villa G; Cominelli F; Pinzani M; Buzzelli G
Gastroenterology; 1988 Jun; 94(6):1470-7. PubMed ID: 3360268
[TBL] [Abstract][Full Text] [Related]
19. Arachidonic acid derivatives and renal function in liver cirrhosis.
Laffi G; La Villa G; Pinzani M; Marra F; Gentilini P
Semin Nephrol; 1997 Nov; 17(6):530-48. PubMed ID: 9353864
[TBL] [Abstract][Full Text] [Related]
20. Role of thromboxane A2 in healing of gastric ulcers in rats.
Takahashi S; Shigeta J; Ishikawa M; Kobayashi N; Okabe S
Jpn J Pharmacol; 1999 Jan; 79(1):101-7. PubMed ID: 10082323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
